Guangzheng Eye Hospital GroupLtd Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Yonglin Zhou

Chief executive officer

CN¥1.3m

Total compensation

CEO salary percentage	n/a
CEO tenure	16.4yrs
CEO ownership	0.05%
Management average tenure	2yrs
Board average tenure	4.7yrs

Recent management updates

Recent updates

Guangzheng Eye Hospital Group Co.,Ltd. (SZSE:002524) May Have Run Too Fast Too Soon With Recent 28% Price Plummet

Jun 06

Guangzheng Eye Hospital Group Co., Ltd.'s (SZSE:002524) Shares Climb 26% But Its Business Is Yet to Catch Up

Mar 18

CEO

Yonglin Zhou (58 yo)

16.4yrs

Tenure

CN¥1,271,100

Compensation

Mr. Yonglin Zhou is Chairman and General Manager of Guangzheng Eye Hospital Group Co., Ltd and has been its Director since June 25, 2008.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Yonglin Zhou	Chairman & GM	no data	CN¥1.27m	0.053% CN¥ 1.0m
Li Junying	CFO & Director	13.1yrs	CN¥828.60k	0.078% CN¥ 1.5m
Jianmin Wang	Deputy GM & Director	no data	CN¥988.80k	0.068% CN¥ 1.3m
Tiejun Wang	Deputy GM & Non-Independent Director	6.3yrs	CN¥966.10k	0.097% CN¥ 1.9m
Wenling Wang	Chief Economist	2yrs	CN¥587.70k	0.0023% CN¥ 44.3k
Zhifang Chen	Deputy General Manager	1.7yrs	CN¥906.70k	0.037% CN¥ 720.0k
Qi Wang	Accounting Supervisor	no data	no data	no data
Wei Li	Secretary	2yrs	no data	no data

2.0yrs

Average Tenure

51yo

Average Age

Experienced Management: 002524's management team is considered experienced (2 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Yonglin Zhou	Chairman & GM	16.4yrs	CN¥1.27m	0.053% CN¥ 1.0m
Li Junying	CFO & Director	3yrs	CN¥828.60k	0.078% CN¥ 1.5m
Jianmin Wang	Deputy GM & Director	6.4yrs	CN¥988.80k	0.068% CN¥ 1.3m
Tiejun Wang	Deputy GM & Non-Independent Director	3yrs	CN¥966.10k	0.097% CN¥ 1.9m
Xin Feng	Non-Independent Director	16.4yrs	CN¥10.00k	no data
Yong Wang	Non-Independent Director	16.4yrs	CN¥10.00k	no data
Hongxin Yang	Chairman of the Supervisory Board	6.4yrs	no data	0.0040% CN¥ 77.6k
Yitao Song	Non-Employee Supervisor	3yrs	no data	no data
Aimin Yan	Independent Director	3yrs	CN¥120.00k	no data
Jian Ge	Independent Director	3yrs	CN¥120.00k	no data
Shiqiao Zheng	Independent Director	3yrs	CN¥120.00k	no data
Weili Li	Supervisor	6.4yrs	no data	0.0024% CN¥ 47.0k

4.7yrs

Average Tenure

55.5yo

Average Age

Experienced Board: 002524's board of directors are considered experienced (4.7 years average tenure).

Guangzheng Eye Hospital GroupLtd Management

Management criteria checks 2/4

Key information

Recent management updates

Guangzheng Eye Hospital Group Co.,Ltd., Annual General Meeting, May 20, 2024

High number of new directors

High number of new directors

Guangzheng Eye Hospital Group Co., Ltd., Annual General Meeting, May 20, 2022

Recent updates

Third quarter 2024 earnings released

Guangzheng Eye Hospital Group Co.,Ltd. to Report Q3, 2024 Results on Oct 25, 2024

Second quarter 2024 earnings released

Guangzheng Eye Hospital Group Co.,Ltd. to Report First Half, 2024 Results on Aug 28, 2024

Guangzheng Eye Hospital Group Co.,Ltd. (SZSE:002524) May Have Run Too Fast Too Soon With Recent 28% Price Plummet

First quarter 2024 earnings released: CN¥0.04 loss per share (vs CN¥0.02 loss in 1Q 2023)

Guangzheng Eye Hospital Group Co.,Ltd., Annual General Meeting, May 20, 2024

Guangzheng Eye Hospital Group Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024

Guangzheng Eye Hospital Group Co., Ltd.'s (SZSE:002524) Shares Climb 26% But Its Business Is Yet to Catch Up

Guangzheng Eye Hospital Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 25, 2024

Third quarter 2023 earnings released: EPS: CN¥0.01 (vs CN¥0.42 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.02 (vs CN¥0.051 loss in 2Q 2022)

New major risk - Revenue and earnings growth

First quarter 2023 earnings released: CN¥0.02 loss per share (vs CN¥0.07 loss in 1Q 2022)

Now 22% undervalued after recent price drop

Now 21% undervalued after recent price drop

Now 21% undervalued

High number of new directors

Now 21% undervalued

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.42 (vs CN¥0.03 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.051 loss per share (vs CN¥0.04 profit in 2Q 2021)

Full year 2021 earnings released: EPS: CN¥0.085 (vs CN¥0.085 in FY 2020)

High number of new directors

Guangzheng Eye Hospital Group Co., Ltd., Annual General Meeting, May 20, 2022

Full year 2021 earnings released: EPS: CN¥0.09 (vs CN¥0.085 in FY 2020)

Fujian Shencheng Energy Trade Co., Ltd entered into share transfer letter of intent to acquire 10% stake in Toksun Xin Tianshan Natural Gas Co., Ltd. from Guangzheng Eye Hospital Group Co., Ltd. (SZSE:002524) CNY 72 million.

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: CN¥0.03 loss per share (vs CN¥0.08 profit in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.04 (vs CN¥0.056 loss in 2Q 2020)

Full year 2020 earnings released: EPS CN¥0.08 (vs CN¥0.14 in FY 2019)

New 90-day low: CN¥10.03

New 90-day low: CN¥10.61

New 90-day low: CN¥11.46

New 90-day high: CN¥13.40

Guangzheng Group Co.,Ltd to Report Q3, 2020 Results on Oct 23, 2020

New 90-day high - CN¥13.28

Guangzheng Group Co.,Ltd to Report First Half, 2020 Results on Aug 25, 2020

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age